Literature DB >> 9099782

Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae in children with sickle cell disease.

N C Daw1, J A Wilimas, W C Wang, G J Presbury, R E Joyner, S C Harris, Y Davis, G Chen, P J Chesney.   

Abstract

OBJECTIVE: We studied the prevalence of nasopharyngeal (NP) carriage, antimicrobial susceptibilities, and serotypes of Streptococcus pneumoniae (SP) in children with sickle cell disease (SCD) in the Mid-South. In addition, we examined risk factors for NP carriage of penicillin-resistant SP (PRSP). STUDY
DESIGN: Between July 1994 and December 1995, we obtained NP cultures from 312 children with SCD followed at the Mid-South Sickle Cell Center, 208 (67%) of whom were receiving penicillin prophylaxis.
RESULTS: Among the 312 patients, colonization with SP occurred in 42 (13%), 30 (71%) of whom were receiving penicillin prophylaxis. Twenty-three of the 42 SP isolates (55%) were resistant to penicillin; 5 of the 23 (22%) were highly resistant. PRSP organisms were also resistant to cefotaxime (43%), trimethoprim-sulfamethoxazole (57%), and erythromycin (22%). Serotypes 6A, 6B, 14, 19A, and 23F accounted for 19 (90%) of 21 resistant strains. Children who were treated with antibiotics during the preceding month were more likely to carry PRSP than children who were not treated.
CONCLUSIONS: There is a high prevalence of NP carriage of PRSP in children with SCD in the Mid-South, which raises concerns regarding the continued effectiveness of penicillin prophylaxis in these children. Further studies on the antimicrobial susceptibilities of resistant organisms and the relationship between NP carriage of SP and invasive disease are needed before developing new recommendations for prophylaxis and treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9099782     DOI: 10.1542/peds.99.4.e7

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.

Authors:  Caroline A Obert; Martha L Miller; Jeremy Montgomery; Thomas Adamkiewicz; Elaine I Tuomanen
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

Review 2.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2017-10-10

3.  Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Authors:  Robert Carter; Joshua Wolf; Tim van Opijnen; Patricia M Flynn; Elaine I Tuomanen; Jason W Rosch; Martha Muller; Caroline Obert; Corinna Burnham; Beth Mann; Yimei Li; Randall T Hayden; Tamara Pestina; Derek Persons; Andrew Camilli
Journal:  Cell Host Microbe       Date:  2014-05-14       Impact factor: 21.023

4.  Nasopharyngeal carriage rate of Streptococcus pneumoniae in Ugandan children with sickle cell disease.

Authors:  David P Kateete; Henry Kajumbula; Deogratias H Kaddu-Mulindwa; Augustine K Ssevviri
Journal:  BMC Res Notes       Date:  2012-01-13

5.  Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing.

Authors:  Selvi C Ersoy; Douglas M Heithoff; Lucien Barnes; Geneva K Tripp; John K House; Jamey D Marth; Jeffrey W Smith; Michael J Mahan
Journal:  EBioMedicine       Date:  2017-05-29       Impact factor: 8.143

6.  Deciphering the distance to antibiotic resistance for the pneumococcus using genome sequencing data.

Authors:  Fredrick M Mobegi; Amelieke J H Cremers; Marien I de Jonge; Stephen D Bentley; Sacha A F T van Hijum; Aldert Zomer
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

7.  Pneumococcal carriage among sickle cell disease patients in Accra, Ghana: Risk factors, serotypes and antibiotic resistance.

Authors:  Nicholas T K D Dayie; Georgina Tetteh-Ocloo; Appiah-Korang Labi; Edeghonghon Olayemi; Hans-Christian Slotved; Margaret Lartey; Eric S Donkor
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

8.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2021-03-08

9.  Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana.

Authors:  Eric S Donkor; Ebenezer Foster-Nyarko; Christabel C Enweronu-Laryea
Journal:  Infect Drug Resist       Date:  2013-07-29       Impact factor: 4.003

10.  Cephalosporin-resistant pneumococci and sickle cell disease.

Authors:  Martha L Miller; Caroline A Obert; Geli Gao; Najat C Daw; Patricia Flynn; Elaine Tuomanen
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.